Onset and Maintenance of Efficacy of Subcutaneous Tanezumab in Patients With Moderate to Severe Osteoarthritis of the Knee or Hip
Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2019.02.122
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Elsevier BV